Literature Review

Is there a role for artificial intelligence in end-of-life care for persons with dementia? Perspectives of and recommendations by caregivers and hospice staff Oxford Academic / Innovation in Aging; by Oonjee Oh, Debra Parker Oliver, Karla Washington, George Demiris; 9/26In this study, we explored families’ and staff’s acceptance of AI in hospice dementia care and generated actionable recommendations for AI designers in supporting end-of-life care for persons with dementia... Participants described AI tools as potentially helpful for obtaining information, monitoring patients, managing medications and appointments, providing companionship, and conducting logistical tasks... The uniqueness of hospice, encompassing its humanistic nature and emphasis on families as part of the care unit, also emerged as a key factor impacting attitudes towards AI use... Families and frontline staff should not be considered merely as end users, but as key stakeholders whose needs and expertise should shape the direction of AI applications.

[Germany] Unmet needs of heart failure patients across the different domains of palliative care – A qualitative interview studyHeart & Lung; by Chiara Pfeffer, Felix Schoenratha, Lennart Tügend, Anahita Khamseh, Susanne Jöbges, Johann Ahne, Asita Behzadie, Moritz Blum; 9/26Currently, palliative care provision for patients with heart failure (HF) is limited and usually not tailored to the specific needs they might have. In this study, we sought to gain a better understanding of the needs and expectations expressed by patients with HF regarding palliative care. Participants expressed needs and expectations across all eight domains of palliative care. Some needs were specific to HF, e.g. for more HF expertise among all healthcare providers. Other needs were more generally associated with serious illnesses, e.g. long term access to psychological counselling for patients and caregivers, help with coming to terms with limited life expectancy, or provision of information in accessible language. Patients with HF express a host of unmet needs, many of which could be addressed by palliative care.

IBM study finds 60% of employees worry AI is eroding critical thinking skills Complete AI Training; 9/21/26 A new IBM study finds that 60% of employees worry AI is eroding their skills, with critical thinking cited most often as declining. The research, released September 21, 2026, surveyed 1,500 CHROs and 8,800 employees globally, revealing a gap between the skills HR leaders say AI demands and what workers prioritize. While 71% of CHROs identify the ability to supervise, validate and override AI outputs as the workforce's most essential skill, only 29% of employees rank judgment as important. At the same time, CHROs cite critical thinking (57%) and human judgment (48%) as among the most important workforce capabilities.

Missed opportunities for goals-of-care conversations in a patient with end-stage juvenile Huntington’s disease: A case reportAmerican Journal of Hospice & Palliative Medicine; by Ignacio Borque, Nuria Perez ´ de Lucas, Alicia Gonzalez, Eduardo Bruera; 8/26Juvenile Huntington’s disease (JHD) is a rare, severe neurodegenerative disorder with early onset, high symptom burden, and a predictable trajectory toward advanced disability and premature death. Despite this, goals-of-care (GOC) conversations and advance care planning are often delayed, leading to reactive, crisis-driven decisions and increased emotional burden for families and clinicians. We present a 30-year-old woman with genetically confirmed JHD, diagnosed at age 14, who declined progressively over more than 15 years. Despite longstanding neurological follow-up and repeated hospital admissions, palliative care referral occurred only 20 days before death. Late palliative care integration limited anticipatory planning and shifted complex decisions into a stage with little room for deliberation, when cognitive and clinical deterioration constrained meaningful participation.

Top ten tips palliative care clinicians should know when caring for seriously ill patients with stimulant use disordersJournal of Palliative Medicine; by Rebekka DePew, Nicole Dussault, Kyle Quirk, Erin Vipler, Josh Borris, Sandra DiScala, Teddy Scheel, Katrina Nickels, Gregg Robbins-Welty, Janet Ho; 8/26Stimulant use disorder (StUD) is common in the hospice and palliative care (PC) setting, though guidance for clinicians remains limited. Stigma around stimulant use is widespread and can lead to impaired clinician/patient communication, poor symptom control, and lower quality of care. PC clinicians should be able to diagnose StUD, understand the potential pharmacologic and nonpharmacologic management options, engage with patients in a trauma-informed way, and refer to addiction medicine colleagues when appropriate. When utilizing opioids for pain management, PC clinicians should be aware of the impact of stimulant use on opioid risk and toxicity. In this article, a multidisciplinary group of PC, hospice, addiction medicine, psychiatry, ethics, and pharmacy clinicians presents ten practical tips for caring for seriously ill patients with current or prior StUD.

Effective palliative care for hospice transitionsJAMA Internal Medicine; by May Hua, MD, MS, Miguel Cid, MPH, Claire Barshied, PhD, Rachel C. Shelton, ScD, MPH, Grace Hu, MPH, Natasha Stekl, MPH, Carrie Brill, BS5; Elise C. Carey, MD, and R. Sean Morrison, MD; 9/14/26 Question: What factors impact the ability of palliative care teams to affect hospice use for patients with metastatic cancer?Findings: In this qualitative study across 6 sites with interviews among 93 clinicians and patients, institutions with high and low performance in hospice use exhibited substantive differences in the relationship between palliative care and oncology teams. At high-performing sites, the relationship was characterized by mutual trust and respect, warmth and familiarity, and empathy for each other, while at low-performing sites, the relationship was characterized by a lack of trust and familiarity as well as negative regard for each other.Meaning: These findings suggest that the relationship between palliative care and oncology teams is a modifiable factor that could affect care delivery and patient outcomes.

Perceived importance of good death components among patients with advanced cancer and family caregivers JAMA Network; by Hammoda Abu-Odah, PhD, Gulbeyaz Can, PhD, Sotirios Plakas, PhD, Juanjuan Zhao, PhD, Xixi Wang, MSN, Alexandros Stergiou, MSc(c), Ourania Govina, PhD, Kimya Kilicaslan, PhD, Bahar Ozdemir, MD, Matthew J. Allsop, PhD, Mitsunori Miyashita, PhD, Alex Molassiotis, PhD, Janelle Yorke, PhD, and Frances Kam Yuet Wong, PhD; 9/14/26Importance: Although the concept of a good death is central to palliative care policy and practice, empirical evidence is largely derived from high-income Western or single-country contexts, limiting cross-setting relevance.Objective: To determine the importance of good death components, compare priorities across settings, and examine patient–caregiver differences and setting-by-role interactions. ... Conclusions and Relevance: In this cross-sectional study, patients with advanced cancer and family caregivers across 5 settings shared a broad aspiration for a good death, but priorities varied across settings. Emotional peace, dignity, and family connection were consistently highly valued. These findings suggest that culturally sensitive palliative care models should recognize both shared end-of-life priorities and setting-specific meanings of a good death.

PHarmacist avoidance or reductions in medical costs in PALLiative care inpatient services: PHARM-PALLJournal of Palliative Medicine; by Celena Wilson, Jennifer Ku; 8/26Inpatient palliative care (PC) pharmacists have been shown to improve clinical and team outcomes. To quantify the cost avoidance (CA) associated with a full-time inpatient PC pharmacist based on clinical interventions. Conclusions: A PC pharmacist may help avoid significant health care costs, particularly in the areas of deprescribing, identifying untreated indications, and using PC expertise to make therapeutic recommendations.